BiancaMed
BiancaMed was co-founded by Dr Conor Heneghan, Dr Philip de Chazal and Dr Conor Hanley in 2003 as a UCD spin-out company, and became one of NovaUCD’s first client companies.
BiancaMed developed a pioneering product that radically changed how sleep disordered-breathing is diagnosed. At the heart of the company’s technology was a highly sensitive, radio frequency motion sensor that detected respiration and movement without being connected to the body.
By 2011 the company had raised over €11 million in funding and grown to a staff of nearly 30 people when it was acquired by ResMed Inc, one of BiancaMed’s early investors. ResMed Inc, headquartered in California, are pioneers in innovative medtech solutions to transform care for people with sleep apnoea, COPD and other chronic diseases.
BiancaMed was renamed ResMed Sensor Technologies and relocated to NexusUCD, and as a division of ResMed Inc it developed or enhanced many of ResMed’s digital innovations. In 2022 the company moved from NexusUCD to a new €30 million technology R&D facility in Sandyford, Co. Dublin and announced plans to add 70 jobs over the next four years.
Equinome
Equinome was co-founded by Professor Emmeline Hill in partnership with Jim Bolger, the renowned Irish trainer and breeder, in 2009 as a spin-out from the UCD School of Agriculture and Food Science. The company was established to commericalise groundbreaking research, funded by Science Foundation Ireland, and led by Professor Hill, which resulted in the identification of what is now referred to as the ‘Speed Gene’, in Thoroughbred horses.
The company, headquartered at NovaUCD, developed a comprehensive series of athletic performance genomic tests for the Thoroughbred market including the Equinome Speed Gene Test and the Equinome Elite Performance Test. The company achieved global reach and sales and significantly changed breeding techniques in the international, multi-billion euro Thoroughbred horse racing and breeding industry.
In 2014 Professor Hill received the NovaUCD Innovation Award and in 2015 the company, which had become a leading global bloodstock genomic testing company, was acquired by Plusvital.
Logentries
Logentries was co-founded by Dr Trevor Parsons and Dr Viliam Holub in 2010 as a spin-out from UCD’s Performance Engineering Laboratory after a decade of joint research with IBM. Logentries developed a SaaS based, log management service for collecting and analyzing big data and making this data easily accessible to improve IT and business operations.
By 2015, Logentries had secured $11 million in funding, had some 70 employees and was serving more than 3,000 customers in over 65 countries across a diverse set of industries when Rapid7, a leading US provider of security data and analytics solutions, acquired the company for over €68 million.
.jpg)
Oxymem
Oxymem a cleantech company, was co-founded by Wayne Byrne, Professor Eoin Casey and Dr Eoin Syron in 2013 as a spin-out from the UCD School of Chemical and Bioprocess Engineering.
The company’s Membrane-Aerated Biofilm Reactor (MABR) technology, a breakthrough technology that focuses on wastewater aeration, makes the wastewater treatment process 75% more energy efficient than conventional treatment technology.
By 2019 the company had grown significantly, employing over 60 people, with a manufacturing site in Athlone, Co. Westmeath and had secured significant investment and major clients around the world when, DuPont, a global innovation leader, acquired the company.